AstraZeneca says no supply snags so far from Red Sea disruptions
By Divya Chowdhury and Savio Shetty DAVOS, Switzerland (Reuters) – Drugmaker AstraZeneca has not seen any supply issues so far due to Red Sea shipping disruptions, a top executive told Reuters ahead…
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
By Daniel Wiessner (Reuters) – AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses…
AstraZeneca drug combo gets US nod to treat a type of prostate cancer
(Reuters) – AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.…
AstraZeneca CEO Soriot says to work with new chairman for many years
FRANKFURT – Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023, for many years to…
S.Korea authorises AstraZeneca COVID therapy Evusheld for vulnerable people
SEOUL – South Korea on Thursday authorised AstraZeneca PLC’s antibody-based therapy for preventing COVID-19 infection in people with a poor immune response, increasing its options as it works to ease the pandemic…
New data sets stage for broader use of AstraZeneca breast cancer drug
By Natalie Grover LONDON – AstraZeneca and Daiichi Sankyo’s Enhertu extended survival by more than six months in patients with a form of advanced breast cancer compared to standard chemotherapy, according to…
AstraZeneca China summoned over suspected fraud
BEIJING -Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company’s employees, the National Healthcare Security Administration (NHSA) said on Saturday. The regulator of…
Breaking News
